About
Built for the people
commercializing science.
Vainture is incubated by CelesiumAI and based in Houston, Texas. We take an invention from disclosure to a practitioner-ready filing — replacing months of manual commercialization and patentability analysis with AI-driven evaluation, then routing the invention to the right filing instrument and preparing the application for a licensed practitioner to review, sign, and file.
Our Story
Incubated by CelesiumAI.
Vainture was created in 2026 to solve a problem the Houston research ecosystem keeps running into: exceptional science failing to reach patients or markets — not because the ideas are bad, but because institutional evaluation bottlenecks make them invisible or mis-prioritized.
The discipline that makes investment committees effective — filter rigorously, de-risk what survives — had never been operationalized for the academic commercialization pipeline. Vainture is that system.
Developed in collaboration with faculty across Houston's leading research institutions, including Baylor College of Medicine, Rice University, MD Anderson Cancer Center, and the Texas Medical Center. Designed for the decision rooms where science meets capital.
How Vainture works
Evaluate, route, prepare.
Two engines answer the evaluation questions. Vainture Signal scores commercialization viability across six dimensions; Vainture Patent assesses patentability against seven prior art sources — independent verdicts that run in parallel when both questions are open. From a fileable verdict, the Filing Platform routes the invention to the right instrument and prepares the provisional or non-provisional application. A licensed practitioner reviews, signs, and files as the final step — Vainture never files and never gives legal advice.
01 — Evaluate
Vainture Signal + Vainture Patent
Scientists submit ideas or paste existing IP. Signal returns a commercialization report across six dimensions; Patent runs a 7-source prior art search and returns a defensibility verdict, draft claims at three scope levels, and a practitioner-ready handoff.
02 — Route
Filing Strategy router
A short strategy interview plus the engine's outputs produce a recommended filing pathway across eight options — reasoning cited to 35 U.S.C. and MPEP, §101 eligibility flags raised, confidence never overstated. Decision support for practitioner confirmation.
03 — Prepare
Application Preparation studio
A guided inventor interview drives section-by-section drafting grounded only in the disclosure, checked by a live accuracy panel, reviewed by a practitioner with HIGH-flag sign-off guards, and exported as page-numbered DOCX/PDF with an auto-generated IDS.
Who it's for
Built for the people commercializing science.
Research Institutions
Baylor College of Medicine, Rice University, MD Anderson, UH, UTHealth
Replace manual evaluation of invention disclosures. Move faster on the ones that matter, decline the ones that don't — with evidence.
Venture Firms
Seed and Series A biotech, medtech, digital health
See investment-ready opportunities surfaced from institutional pipelines. Use the same AI evaluation as part of due diligence.
Operators & Investors
Fund managers, tech-transfer leaders, research VPs
Benchmark your pipeline against therapeutic-area trends. Know which bets are supported by the market — and which aren't.
Talk with us.
Vainture is currently onboarding institutional partners and venture firms. If that's you, we'd like to hear what you're working on.
Request Access